Patents by Inventor Alexander Gall

Alexander Gall has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • SULFORHODAMINE PHOSPHORAMIDITE DYES
    Publication number: 20250051577
    Abstract: Automated oligonucleotide synthesis-compatible sulforhodamine dye phosphoramidite compounds and labeled polynucleotides incorporating these dyes are provided.
    Type: Application
    Filed: August 19, 2024
    Publication date: February 13, 2025
    Applicant: CEPHEID
    Inventors: Kevin P. LUND, Dmitri SERGUEEV, Maher N. QABAR, Alexander GALL
  • Sulforhodamine phosphoramidite dyes
    Patent number: 12071547
    Abstract: Automated oligonucleotide synthesis-compatible sulforhodamine dye phosphoramidite compounds and labeled polynucleotides incorporating these dyes are provided.
    Type: Grant
    Filed: May 7, 2019
    Date of Patent: August 27, 2024
    Assignee: Cepheid
    Inventors: Kevin P. Lund, Dmitri Sergueev, Maher N. Qabar, Alexander Gall
  • SULFORHODAMINE PHOSPHORAMIDITE DYES
    Publication number: 20240067824
    Abstract: Automated oligonucleotide synthesis-compatible sulforhodamine dye phosphoramidite compounds and labeled polynucleotides incorporating these dyes are provided.
    Type: Application
    Filed: May 7, 2019
    Publication date: February 29, 2024
    Inventors: Kevin P. LUND, Dmitri SERGUEEV, Maher N. QABAR, Alexander GALL
  • Fluorescent dyes
    Patent number: 11807643
    Abstract: Automated oligonucleotide synthesis-compatible fluorescent dye phosphoramidite compounds, solid supports, and labeled polynucleotides incorporating the compounds are provided. The compounds allow universal incorporation of the fluorescent label into any position of the polynucleotide.
    Type: Grant
    Filed: July 13, 2021
    Date of Patent: November 7, 2023
    Assignee: Cepheid
    Inventors: Kevin P. Lund, Dmitri Sergueev, Alexander Gall
  • Integrated purification and measurement of DNA methylation and co-measurement of mutations and/or MRNA expression levels in an automated reaction cartridge
    Patent number: 11603555
    Abstract: In various embodiments methods of determining methylation of DNA are provided.
    Type: Grant
    Filed: June 14, 2016
    Date of Patent: March 14, 2023
    Assignee: CEPHEID
    Inventors: Edwin W. Lai, Andrew Kohlway, Reuel Vanatta, Russell Higuchi, Alexander Gall, Kriszten Kocmond
  • FLUORESCENT DYES
    Publication number: 20220017531
    Abstract: Automated oligonucleotide synthesis-compatible fluorescent dye phosphoramidite compounds, solid supports, and labeled polynucleotides incorporating the compounds are provided. The compounds allow universal incorporation of the fluorescent label into any position of the polynucleotide.
    Type: Application
    Filed: July 13, 2021
    Publication date: January 20, 2022
    Applicant: Cepheid
    Inventors: Kevin P. Lund, Dmitri Sergueev, Alexander Gall
  • INTEGRATED PURIFICATION AND MEASUREMENT OF DNA METHYLATION AND CO-MEASUREMENT OF MUTATIONS AND/OR MRNA EXPRESSION LEVELS IN AN AUTOMATED REACTION CARTRIDGE
    Publication number: 20170137871
    Abstract: In various embodiments methods of determining methylation of DNA are provided.
    Type: Application
    Filed: June 14, 2016
    Publication date: May 18, 2017
    Inventors: EDWIN W. LAI, ANDREW KOHLWAY, REUEL VANATTA, RUSSELL HIGUCHI, ALEXANDER GALL, KRISZTEN KOCMOND
  • Prodrugs of heteroaryl compounds
    Patent number: 8324379
    Abstract: The present invention provides hydrophobic prodrugs of bases, nucleosides, and nucleotides as well as methods of using the prodrugs as antiviral and anti-cancer chemotherapeutic agents.
    Type: Grant
    Filed: May 16, 2011
    Date of Patent: December 4, 2012
    Assignee: Koronis Pharmaceuticals, Inc.
    Inventors: Richard Daifuku, Alexander Gall, Dmitri Sergueev, Dina Sologub, Kevin Harris
  • Prodrugs of Heteroaryl Compounds
    Publication number: 20110224434
    Abstract: The present invention provides hydrophobic prodrugs of bases, nucleosides, and nucleotides as well as methods of using the prodrugs as antiviral and anti-cancer chemotherapeutic agents.
    Type: Application
    Filed: May 16, 2011
    Publication date: September 15, 2011
    Applicant: Koronis Phamaceuticals, Incorporated
    Inventors: Richard Daifuku, Alexander Gall, Dmitri Sergueev, Dina Sologub, Kevin Harris
  • Prodrugs of heteroaryl compounds
    Patent number: 7982034
    Abstract: The present invention provides hydrophobic prodrugs of bases, nucleosides, and nucleotides as well as methods of using the prodrugs as antiviral and anti-cancer chemotherapeutic agents.
    Type: Grant
    Filed: April 7, 2009
    Date of Patent: July 19, 2011
    Assignee: Koronis Pharmaceuticals, Incorporated
    Inventors: Richard Daifuku, Alexander Gall, Dmitri Sergueev, Dina Sologub, Kevin Harris
  • Mutagenic Nucleoside Analogs for the Treatment of Viral Disease
    Publication number: 20100279968
    Abstract: The present invention relates to methods of treating viral disease using mutagenic nucleoside analogs.
    Type: Application
    Filed: December 27, 2006
    Publication date: November 4, 2010
    Applicant: Koronis Pharmaceuticals, Inc.
    Inventors: Ling Li, Alexander Gall, Richard Daifuku
  • 1,3,5-triazines for treatment of viral diseases
    Patent number: 7772197
    Abstract: The present invention provides compounds and methods for treatment of viral diseases and cancer.
    Type: Grant
    Filed: September 24, 2003
    Date of Patent: August 10, 2010
    Assignee: 1,3,5-Triazines for Treatment of Viral Diseases
    Inventors: Richard Daifuku, Alexander Gall, Dmitri Sergueev
  • Mutagenic nucleoside analogs for the treatment of viral disease
    Patent number: 7648967
    Abstract: The present invention relates to methods of treating viral disease using mutagenic nucleoside analogs. In particular, the invention provides isoguanosine nucleosides and derivatives thereof as well a method of increasing the mutation rate of a virus such as bovine viral diarrhea virus (BVDV) and hepatitis C virus (HCV).
    Type: Grant
    Filed: February 13, 2006
    Date of Patent: January 19, 2010
    Assignee: Koronis Pharmaceuticals, Incorporated
    Inventors: Ling Li, Alexander Gall, Richard Daifuku
  • 1,3,5-triazines for treatment of viral diseases
    Patent number: 7642247
    Abstract: The present invention provides compounds and methods for treatment of viral diseases and cancer.
    Type: Grant
    Filed: February 6, 2007
    Date of Patent: January 5, 2010
    Assignee: Koronis Pharmaceuticals, Incorporated
    Inventors: Richard Daifuku, Alexander Gall, Dmitri Sergueev
  • Prodrugs of heteroaryl compounds
    Patent number: 7589092
    Abstract: The present invention provides hydrophobic prodrugs of bases, nucleosides, and nucleotides as well as methods of using the prodrugs as antiviral and anti-cancer chemotherapeutic agents.
    Type: Grant
    Filed: December 27, 2006
    Date of Patent: September 15, 2009
    Assignee: Koronis Pharmaceuticals, Incorporated
    Inventors: Richard Daifuku, Alexander Gall, Dmitri Sergueev, Dina Sologub, Kevin Harris
  • PRODRUGS OF HETEROARYL COMPOUNDS
    Publication number: 20090209505
    Abstract: The present invention provides hydrophobic prodrugs of bases, nucleosides, and nucleotides as well as methods of using the prodrugs as antiviral and anti-cancer chemotherapeutic agents.
    Type: Application
    Filed: April 7, 2009
    Publication date: August 20, 2009
    Applicant: Koronis Pharmaceuticals, Incorporated
    Inventors: Richard Daifuku, Alexander Gall, Dmitri Sergueev, Dina Sologub, Kevin Harris
  • PRODRUGS OF HETEROARYL COMPOUNDS
    Publication number: 20090192099
    Abstract: The present invention provides hydrophobic prodrugs of bases, nucleosides, and nucleotides as well as methods of using the prodrugs as antiviral and anti-cancer chemotherapeutic agents.
    Type: Application
    Filed: March 30, 2009
    Publication date: July 30, 2009
    Applicant: Koronis Pharmaceuticals, Incorporated
    Inventors: Richard Daifuku, Alexander Gall, Dmitri Sergueev, Dina Sologub, Kevin Harris
  • PRODRUGS OF HETEROARYL COMPOUNDS
    Publication number: 20080249097
    Abstract: The present invention provides hydrophobic prodrugs of bases, nucleosides, and nucleotides as well as methods of using the prodrugs as antiviral and anti-cancer chemotherapeutic agents.
    Type: Application
    Filed: December 27, 2006
    Publication date: October 9, 2008
    Applicant: Koronis Pharmaceuticals, Incorporation
    Inventors: Richard Daifuku, Alexander Gall, Dmitri Sergueev, Dina Sologub, Kevin Harris
  • Mutagenic Heterocycles
    Publication number: 20080033172
    Abstract: The present invention provides compounds as well as methods of using the compounds as antiviral and anti-cancer chemotherapeutic agents.
    Type: Application
    Filed: December 10, 2004
    Publication date: February 7, 2008
    Applicant: Koronis Pharmaceuticals, Incorporated
    Inventors: Richard Daifuku, Alexander Gall, Dmitri Sergueev
  • MUTAGENIC HETEROCYCLES
    Publication number: 20080009496
    Abstract: The present invention provides compounds as well as methods of using the compounds as antiviral and anti-cancer chemotherapeutic agents.
    Type: Application
    Filed: December 27, 2006
    Publication date: January 10, 2008
    Applicant: Koronis Pharmaceuticals, Inc.
    Inventors: Richard Daifuku, Alexander Gall, Dmitri Sergueev